Who
Michelle Renee Griffin
Director
Company insider
Files Form 4 as: Director, Adaptive Biotechnologies; Director, Chinook Therapeutics; Director, Acer Therapeutics; Director, Htg Molecular Diagnostics; Director, Phaserx; CFO, Achieve Life Sciences; Senior V.P. and C.O.O., Trubion Pharmaceuticals.
In numbers
- Trades disclosed
- 117
- Buys
- 0
- Sells
- 19
- Bought
- $0
- Sold
- $7.9M
- Companies
- 7
- Companies where not an officer
- 5
- First trade
- 9 May 2006
- Last trade
- 25 Jun 2026
- Last filed
- 29 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 25 Jun 2026filed 29 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $406K52,084 at $7.80 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $1.1M52,084 at $20.18 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —52,084 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —52,084 at $0.00 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $406K52,084 at $7.80 | filing |
| 25 Jun 2026filed 29 Jun 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $1.1M52,084 at $20.18 | filing |
| 11 Mar 2026filed 13 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $214K15,394 at $13.91 | filing |
| 11 Mar 2026filed 13 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $214K15,394 at $13.91 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —15,625 at $0.00 | filing |
| 4 Mar 2026filed 6 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —15,625 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $192K48,044 at $3.99 | filing |
| 3 Mar 2026filed 5 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $735K48,044 at $15.30 | filing |
| 3 Mar 2026filed 5 Mar 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —48,044 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —48,044 at $0.00 | filing |
| 3 Mar 2026filed 5 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code M | $192K48,044 at $3.99 | filing |
| 3 Mar 2026filed 5 Mar 2026 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $735K48,044 at $15.30 | filing |
| 13 Mar 2025filed 17 Mar 2025 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $261K36,291 at $7.19 | filing |
| 6 Mar 2025filed 6 Mar 2025 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Sold | $124K15,664 at $7.94 | filing |
| 4 Mar 2025filed 6 Mar 2025 | ADPT Adaptive Biotechnologiesoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —23,726 at $0.00 | filing |
| 4 Mar 2025filed 6 Mar 2025 | ADPT Adaptive BiotechnologiesDiagnostics & Labs | SEC FORM 4 Code A | —15,394 at $0.00 | filing |
News
Adaptive Biotechnologies (NASDAQ:ADPT) COO Sells 11,881 Shares of Company StockADPT · dailypolitical.com · 21 Oct 2026
0 headlines in the last 90 days name Michelle Renee Griffin; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.